Study Examines Link Between Prescription Opioids and Mental Health Disorders
Overview of the Opioid Epidemic
A recent study investigated the connection between the use of prescription opioids and the prevalence of depression and anxiety disorders. Over the past twenty years, the United States has experienced a dramatic five-fold increase in opioid prescriptions, a phenomenon referred to as the “opioid epidemic.” This surge has been associated with drug misuse and a rise in overdose cases. Concern over chronic opioid use has prompted researchers to delve deeper into the implications of this trend.
Health Risks Associated with Opioid Use
Previous research has indicated that opioid use can result in immunosuppression, neurohormonal deficits, and various other adverse health conditions. Additionally, observational studies have demonstrated a significant correlation between prescription opioids and the incidence of depression and anxiety disorders. However, these observational studies often lack sufficient control measures, rendering them incapable of establishing directionality or causation.
Research Methodology
In response to these limitations, researchers from the United States and England conducted a study aimed at exploring the bidirectional relationship between prescription opioids and mental health disorders. The findings were published in JAMA Psychiatry. The study utilized Mendelian randomization—a method that leverages genetic material to estimate exposure—thereby mitigating some issues associated with observational research. Participants who used various pain medications, including nonsteroidal anti-inflammatory drugs, were also included, as pain management is closely tied to mental health disorders.
Findings on Opioids and Depression
The study, which analyzed data from over 700,000 individuals, revealed genetic evidence linking prescription opioid use to both depression and anxiety disorders. Notably, nonopioid analgesics did not exhibit a similar association with either condition. The research indicated that depression, rather than anxiety disorders, may serve as a potential causal factor for opioid use, highlighting a bidirectional relationship between these variables.
Implications of the Findings
The researchers suggest that opioid consumption may disrupt the brain’s reward circuitry, thereby altering the perception of reward, pleasure, and relief. This dysregulation could contribute to the symptoms associated with major depressive disorder.
Reference
Rosoff DB, Smith GD, Lohoff FW. Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis. JAMA Psychiatry. Published online November 11, 2020. doi:10.1001/jamapsychiatry.2020.3554